Clinical Relevance of Receptor Tyrosine Kinase Gene in Orbital Rhabdomyosarcoma

被引：0
|
作者：
Sen, Seema [1 ]
Chauhan, Sheetal [1 ]
Pushker, Neelam [2 ]
Kashyap, Seema [1 ]
Bakhshi, Sameer [3 ]
机构：
[1] All India Inst Med Sci, Dr RP Ctr, Ocular Pathol, New Delhi, India
[2] All India Inst Med Sci, Ophthalmol, New Delhi, India
[3] All India Inst Med Sci, Dept Med Oncol, New Delhi, India
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2020年 / 61卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4683
引用
收藏
页数：3
相关论文
共 50 条
  • [41] THE LTK GENE ENCODES A NOVEL RECEPTOR-TYPE PROTEIN TYROSINE KINASE
    KROLEWSKI, JJ
    DALLAFAVERA, R
    EMBO JOURNAL, 1991, 10 (10): : 2911 - 2919
  • [42] Molecular analysis of alternative transcripts of equine AXL receptor tyrosine kinase gene
    Park, Jeong-Woong
    Song, Ki-Duk
    Kim, Nam Young
    Choi, Jae-Young
    Hong, Seul A.
    Oh, Jin Hyeog
    Kim, Si Won
    Lee, Jeong Hyo
    Park, Tae Sub
    Kim, Jin-Kyoo
    Kim, Jong Geun
    Cho, Byung-Wook
    ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES, 2017, 30 (10): : 1471 - 1477
  • [43] Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility
    Ma, G. Z. M.
    Stankovich, J.
    Kilpatrick, T. J.
    Binder, M. D.
    Field, J.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (05) : 702 - 702
  • [44] Characterisation and chromosome mapping of the human non receptor tyrosine kinase gene, brk
    Philip J Mitchell
    Karen T Barker
    Janet Shipley
    Mark R Crompton
    Oncogene, 1997, 15 : 1497 - 1502
  • [45] THE MOUSE TIE RECEPTOR TYROSINE KINASE GENE - EXPRESSION DURING EMBRYONIC ANGIOGENESIS
    KORHONEN, J
    POLVI, A
    PARTANEN, J
    ALITALO, K
    ONCOGENE, 1994, 9 (02) : 395 - 403
  • [46] HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy
    De Giovanni, Carla
    Landuzzi, Lorena
    Palladini, Arianna
    Nicoletti, Giordano
    Nanni, Patrizia
    Lollini, Pier-Luigi
    CELLS, 2021, 10 (07)
  • [47] Mapping of receptor tyrosine kinases activation and downstream signaling in rhabdomyosarcoma
    Neradil, Jakub
    Veselska, Renata
    Mudry, Peter
    Melicharkova, Kristyna
    Sterba, Jaroslav
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S78 - S78
  • [48] Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study
    Escudero-Ortiz, Vanesa
    Dominguez-Lenero, Vanessa
    Catalan-Latorre, Ana
    Rebollo-Liceaga, Joseba
    Sureda, Manuel
    PHARMACEUTICS, 2022, 14 (06)
  • [49] Antibody-based targeting of the cell surface receptor tyrosine kinase FGFR4 in rhabdomyosarcoma and other cancers
    Skarzynski, Martin
    Shivaprasad, Nitya
    Subramanian, Baskar
    Azorsa, David
    Zhu, Zhongyu
    Dimitrov, Dimiter
    Khan, Javed
    CANCER RESEARCH, 2017, 77
  • [50] Toxicities of Receptor Tyrosine Kinase Inhibitors in Cancer Pharmacotherapy: Management with Clinical Pharmacology
    Fujita, Ken-ichi
    Ishida, Hiroo
    Kubota, Yutaro
    Sasaki, Yasutsuna
    CURRENT DRUG METABOLISM, 2017, 18 (03) : 186 - 198
12345